Regeneron

For 35 years, our mission has been to use the power of science to bring new medicines to patients… over and over again. Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Regeneron is accelerating and improving the traditional drug development process through its proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. We are the only biopharma company founded and led by physician-scientists since the beginning, more than three decades ago. At Regeneron, we've been committed to making a difference in patients' lives for over 30 years. The commercial organization at Regeneron is responsible and accountable for the really important step of making sure that our medicines get to patients who need them. Alumni of Regeneron’s STEM programs and competitions have won National Medals of Science, Fields Medals and Nobel Prizes.